tradingkey.logo

Bone Biologics Corp

BBLG
1.630USD
0.0000.00%
Market hours ETQuotes delayed by 15 min
2.93MMarket Cap
LossP/E TTM

Bone Biologics Corp

1.630
0.0000.00%

More Details of Bone Biologics Corp Company

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Bone Biologics Corp Info

Ticker SymbolBBLG
Company nameBone Biologics Corp
IPO dateNov 27, 2015
CEOFrelick (Jeffrey)
Number of employees2
Security typeOrdinary Share
Fiscal year-endNov 27
Address2 Burlington Woods Dr Ste 100
CityBURLINGTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01803-4551
Phone17815524452
Websitehttps://www.bonebiologics.com/
Ticker SymbolBBLG
IPO dateNov 27, 2015
CEOFrelick (Jeffrey)

Company Executives of Bone Biologics Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+3.00%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+3.00%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: 17 hours ago
Updated: 17 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
DRW Securities, LLC
0.61%
Geode Capital Management, L.L.C.
0.35%
UBS Financial Services, Inc.
0.11%
Tower Research Capital LLC
0.08%
Frelick (Jeffrey)
0.02%
Other
98.83%
Shareholders
Shareholders
Proportion
DRW Securities, LLC
0.61%
Geode Capital Management, L.L.C.
0.35%
UBS Financial Services, Inc.
0.11%
Tower Research Capital LLC
0.08%
Frelick (Jeffrey)
0.02%
Other
98.83%
Shareholder Types
Shareholders
Proportion
Investment Advisor
0.73%
Investment Advisor/Hedge Fund
0.35%
Hedge Fund
0.08%
Individual Investor
0.04%
Research Firm
0.03%
Other
98.77%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
15
13.28K
0.99%
--
2025Q3
23
14.93K
1.62%
+12.83K
2025Q2
23
2.10K
1.96%
-3.89K
2025Q1
23
5.99K
6.22%
-27.92K
2024Q4
25
11.69K
8.76%
-6.90K
2024Q3
24
17.54K
8.58%
+4.95K
2024Q2
23
11.22K
11.00%
+2.60K
2024Q1
23
8.62K
9.21%
-4.88K
2023Q4
22
1.85K
15.09%
-9.81K
2023Q3
21
11.67K
14.02%
-1.55K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
DRW Securities, LLC
11.03K
0.61%
+11.03K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
--
0%
-4.03K
-100.00%
Jun 30, 2025
UBS Financial Services, Inc.
66.00
0%
-47.00
-41.59%
Sep 30, 2025
Tower Research Capital LLC
1.46K
0.08%
+1.26K
+632.00%
Sep 30, 2025
Frelick (Jeffrey)
359.00
0.02%
+3.00
+0.84%
Apr 11, 2025
Walsh (Deina H)
313.00
0.02%
--
--
Apr 11, 2025
SBI Securities Co., Ltd.
230.00
0.01%
+230.00
--
Sep 30, 2025
Citi Investment Research (US)
206.00
0.01%
+206.00
--
Sep 30, 2025
Clear Street Group Inc
138.00
0.01%
+138.00
--
Sep 30, 2025
Clear Street LLC
138.00
0.01%
+138.00
--
Jun 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Jun 06, 2025
Merger
6→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Jun 06, 2023
Merger
30→1
Date
Ex-dividend Date
Type
Ratio
Jun 06, 2025
Merger
6→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
KeyAI